Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTABLETGeneric

DAPAGLIFLOZIN AND METFORMIN

DAPAGLIFLOZIN || METFORMIN

Standard Dose
1000MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: None (Tentative Approval)
Summary

Approval overview DAPAGLIFLOZIN AND METFORMIN is listed in Drugs@FDA under application 218091 (ANDA).

Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient DAPAGLIFLOZIN || METFORMIN Form and strength TABLET - 1000MG Sponsor SINOTHERAPEUTICS INC Submission history Latest submission status date: 2025-05-08 00:00:00.

Structured Monograph

Clinical summary

Approval overview DAPAGLIFLOZIN AND METFORMIN is listed in Drugs@FDA under application 218091 (ANDA). Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient DAPAGLIFLOZIN || METFORMIN Form and strength TABLET - 1000MG Sponsor SINOTHERAPEUTICS INC Submission history Latest submission status date: 2025-05-08 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: None (Tentative Approval)
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
DAPAGLIFLOZIN AND METFORMIN (DAPAGLIFLOZIN || METFORMIN) | Drug Monograph | MedicHelpline